scorecardresearch
Add as a preferred source on Google
Saturday, January 3, 2026
TopicBiosimilar drugs

Topic: biosimilar drugs

India’s draft guidelines on biosimilar drugs can make treatments more accessible, affordable

Though India has built a robust domestic biosimilar market, its international presence and the ability to lower prices as compared to small molecule generics remain limited.

Don’t let foreign big pharma block biosimilars. Govt should boost access in India

Without widespread access to biosimilars, thousands of cancer patients are losing their battle. Life-saving treatment is not a privilege but a right. The government should understand this.

On Camera

Savitribai Phule made space for radical women misfits. She pioneered Satyashodhak modernity

The distinctiveness of her writing is evident in her compositions—women, shudras, and atishudras are at the center. Her poetry challenges the aesthetics of 'modern' Marathi literature.

India’s urban co-op banks are turning the page—crisis to cautious revival, one metric at a time

With bad loans shrinking & capital buffers stronger, urban co-op banks’ new umbrella body NUCFDC is now prioritising rollout of digital transformation.

Greece looking at TATA’s WhAP infantry combat vehicle for army procurement

If deal goes through, Greece will be 2nd foreign country to procure vehicle. Morocco was first; TATA Group has set up manufacturing unit there with minimum 30 percent indigenous content.

A year-end Mea Culpa in National Interest—The Army-Islam combo doesn’t kill democracy

Many of you might think I got something so wrong in National Interest pieces written this year. I might disagree! But some deserve a Mea Culpa. I’d deal with the most recent this week.